Actelion's macitentan meets goal in study
Actelion's macitentan meets goal in study
ZURICH (Reuters) - Europe's biggest biotech company, Actelion, said on Monday its big drug hope macitentan met its goal in a key late-stage trial, giving a much-needed boost to the company's pipeline. Actelion is banking on the on heart and lung drug to cut its dependence on its main product, Tracleer, which accounts for around 90 percent of group sales and is facing growing competition from Gilead's rival drug, Letairis. ...
Exclusive: China mulls guarantees for ships carrying Iran oil
BEIJING (Reuters) - China is considering sovereign guarantees for its ships to enable the world's second-biggest oil consumer to continue importing Iranian crude after new EU sanctions come into effect in July, the head of China's shipowners' association said. Tough new European Union sanctions aimed at stopping Iran's oil exports to Europe also ban EU insurers and reinsurers from covering tankers carrying Iranian crude anywhere in the world. ...
Clippers rally to tame Grizzlies, Hawks down Celtics
(Reuters) - The Los Angeles Clippers rallied from a 27-point deficit to stun the Memphis Grizzlies 99-98 in Game One of their first-round playoff series.